Biocon Ltd
NSE:BIOCON
Biocon Ltd
Depreciation & Amortization
Biocon Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biocon Ltd
NSE:BIOCON
|
Depreciation & Amortization
-₹15.3B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-23%
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Depreciation & Amortization
-₹1.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
20%
|
CAGR 10-Years
20%
|
|
Transgene Biotek Ltd
BSE:526139
|
Depreciation & Amortization
-₹49.5m
|
CAGR 3-Years
21%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Depreciation & Amortization
-₹70.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-10%
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Depreciation & Amortization
-₹171.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Depreciation & Amortization
-₹391.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
See Also
What is Biocon Ltd's Depreciation & Amortization?
Depreciation & Amortization
-15.3B
INR
Based on the financial report for Dec 31, 2023, Biocon Ltd's Depreciation & Amortization amounts to -15.3B INR.
What is Biocon Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-23%
Over the last year, the Depreciation & Amortization growth was -59%. The average annual Depreciation & Amortization growth rates for Biocon Ltd have been -31% over the past three years , -29% over the past five years , and -23% over the past ten years .